{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:16:05Z","timestamp":1792635365303,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014535","name":"Mayo Clinic Center for Individualized Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014535","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["CA201127"],"award-info":[{"award-number":["CA201127"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI132165"],"award-info":[{"award-number":["AI132165"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R37CA266344"],"award-info":[{"award-number":["R37CA266344"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI179974"],"award-info":[{"award-number":["R01AI179974"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014481","name":"Kite Pharma Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014481","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.omton.2025.200985","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T11:19:01Z","timestamp":1745061541000},"page":"200985","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Intrinsic immunosuppressive features of monocytes suppress CAR-T19 through IL-1 pathway modulation in mantle cell lymphoma"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2782-8527","authenticated-orcid":false,"given":"Kun","family":"Yun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Leo","family":"Sakemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Can","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Gutierrez Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekene J.","family":"Ogbodo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ateka","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Truc N.","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Manriquez Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia L.","family":"Sirpilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carli M.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"Girsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Feigin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Kimball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel A.","family":"Kankeu Fonkoua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Hefazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Ruff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariborz Rakhshan","family":"Rohakhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vernadette","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth L.","family":"Siegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Mattie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sao-Mai","family":"Nguyen-Mau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Filosto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad S.","family":"Kenderian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2025.200985_bib1","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1038\/s41375-023-01976-z","article-title":"Who wins the combat, CAR or TCR?","volume":"37","author":"Yun","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.omton.2025.200985_bib2","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omton.2025.200985_bib3","first-page":"372","article-title":"Mechanisms of resistance to CAR T cell therapy","volume":"16","author":"Shah","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.omton.2025.200985_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.01399","article-title":"Systemic Reprogramming of Monocytes in Cancer","volume":"10","author":"Kiss","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omton.2025.200985_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-20893-2","article-title":"CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy","volume":"12","author":"Rodriguez-Garcia","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2025.200985_bib6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.omto.2022.03.009","article-title":"CAR T cell therapy and the tumor microenvironment: Current challenges and opportunities","volume":"25","author":"Kankeu Fonkoua","year":"2022","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.omton.2025.200985_bib7","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1182\/bloodadvances.2024012563","article-title":"Monocytes in leukapheresis products affect the outcome of CD19\u2013targeted CAR T-cell therapy in patients with lymphoma","volume":"8","author":"Carniti","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.omton.2025.200985_bib8","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1182\/blood.2020007445","article-title":"Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma","volume":"137","author":"Jain","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.200985_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1182\/blood-2020-137045","article-title":"Myc Expression and Tumor-Infiltrating T Cells Are Associated with Response in Patients (Pts) with Relapsed\/Refractory Diffuse Large B-Cell Lymphoma (r\/r DLBCL) Treated with Tisagenlecleucel in the Juliet Trial","volume":"136","author":"Jaeger","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.200985_bib10","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1056\/NEJMoa1914347","article-title":"KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma","volume":"382","author":"Wang","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omton.2025.200985_bib11","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1158\/2159-8290.CD-16-0850","article-title":"Overcoming the immunosuppressive tumor microenvironment of Hodgkin lymphoma using chimeric antigen receptor T cells","volume":"7","author":"Ruella","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.omton.2025.200985_bib12","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1007\/s12094-022-02907-7","article-title":"Cancer cell-derived exosomal LINC00313 induces M2 macrophage differentiation in non-small cell lung cancer","volume":"24","author":"Kong","year":"2022","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.omton.2025.200985_bib13","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1182\/bloodadvances.2020003871","article-title":"Mantle cell lymphoma polarizes tumor-associated macrophages into M2-like macrophages, which in turn promote tumorigenesis","volume":"5","author":"Le","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.omton.2025.200985_bib14","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.4049\/jimmunol.163.4.2168","article-title":"CD40 Ligand-Activated Human Monocytes Amplify Glomerular Inflammatory Responses Through Soluble and Cell-to-Cell Contact-Dependent Mechanisims","volume":"163","author":"Kuroiwa","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.omton.2025.200985_bib15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","article-title":"IL-17 and IL-17-producing cells in protection versus pathology","volume":"23","author":"Mills","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omton.2025.200985_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-03780-z","article-title":"Image based Machine Learning for identification of macrophage subsets","volume":"7","author":"Rostam","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2025.200985_bib17","doi-asserted-by":"crossref","DOI":"10.1186\/s12865-023-00546-3","article-title":"Prevention of M2 polarization and temporal limitation of differentiation in monocytes by extracellular ATP","volume":"24","author":"Scherr","year":"2023","journal-title":"BMC Immunol."},{"key":"10.1016\/j.omton.2025.200985_bib18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cyto.2005.03.007","article-title":"Pre-interleukin-1\u03b1 expression reduces cell growth and increases interleukin-6 production in SaOS-2 osteosarcoma cells: Differential inhibitory effect of interleukin-1 receptor antagonist (icIL-1Ra1)","volume":"31","author":"Palmer","year":"2005","journal-title":"Cytokine"},{"key":"10.1016\/j.omton.2025.200985_bib19","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3390\/biomedicines8120602","article-title":"Roles of Interleukin-1 Receptor Antagonist in Prostate Cancer Progression","volume":"8","author":"Fan","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.omton.2025.200985_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583084","article-title":"Tumor-Associated Macrophages in Tumor Immunity","volume":"11","author":"Pan","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2025.200985_bib21","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-021-02089-2","article-title":"New insights into M1\/M2 macrophages: key modulators in cancer progression","volume":"21","author":"Liu","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.omton.2025.200985_bib22","article-title":"Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy","volume":"13","author":"Gao","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2025.200985_bib23","article-title":"Interleukin-1 as Innate Mediator of T Cell Immunity","volume":"11","author":"Van Den Eeckhout","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2025.200985_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008639","article-title":"Expression and function of TNF and IL-1 receptors on human regulatory T cells","volume":"5","author":"Mercer","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.omton.2025.200985_bib25","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/blood-2009-08-236521","article-title":"Regulating human Th17 cells via differential expression of IL-1 receptor","volume":"115","author":"Lee","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.200985_bib26","article-title":"Transcriptomic signature and metabolic programming of bovine classical and nonclassical monocytes indicate distinct functional specializations","author":"Talker","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.omton.2025.200985_bib27","doi-asserted-by":"crossref","first-page":"R69","DOI":"10.1186\/ar3788","article-title":"Egr-1 contributes to IL-1-mediated down-regulation of peroxisome proliferator-activated receptor \u03b3 expression in human osteoarthritic chondrocytes","volume":"14","author":"Nebbaki","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.omton.2025.200985_bib28","doi-asserted-by":"crossref","first-page":"eabl4896","DOI":"10.1126\/science.abl4896","article-title":"The Tabula Sapiens: A multiple-organ, single-cell transcriptomic atlas of humans","volume":"376","author":"Jones","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.omton.2025.200985_bib29","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/carcin\/bgad067","article-title":"Copine 1 predicts poor clinical outcomes by promoting M2 macrophage activation in ovarian cancer","volume":"44","author":"Sheng","year":"2023","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.omton.2025.200985_bib30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ebiom.2019.05.037","article-title":"TRIM33 deficiency in monocytes and macrophages impairs resolution of colonic inflammation","volume":"44","author":"Petit","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.omton.2025.200985_bib31","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1016700","article-title":"Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells","volume":"4","author":"Wu","year":"2015","journal-title":"OncoImmunology"},{"key":"10.1016\/j.omton.2025.200985_bib32","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1158\/2326-6066.CIR-21-0593","article-title":"Loss of LRRC33-Dependent TGF\u03b21 Activation Enhances Antitumor Immunity and Checkpoint Blockade Therapy","volume":"10","author":"Jiang","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.omton.2025.200985_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104254","article-title":"IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy","volume":"359","author":"Weber","year":"2021","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.omton.2025.200985_bib34","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1084\/jem.20181218","article-title":"Host conditioning with IL-1\u03b2 improves the antitumor function of adoptively transferred T cells","volume":"216","author":"Lee","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.omton.2025.200985_bib35","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrd3800","article-title":"Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases","volume":"11","author":"Dinarello","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omton.2025.200985_bib36","first-page":"1212","article-title":"Interleukin 1 as an Adjuvant for Active Specific Immunotherapy in a Murine Tumor Model1","volume":"50","author":"Mccune2","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2025.200985_bib37","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/s41385-018-0017-4","article-title":"IL-1\u03b2 as mucosal vaccine adjuvant: The specific induction of tissue-resident memory T cells improves the heterosubtypic immunity against influenza A viruses article","volume":"11","author":"Lapuente","year":"2018","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.omton.2025.200985_bib38","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jtct.2023.04.001","article-title":"Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy","volume":"29","author":"Gazeau","year":"2023","journal-title":"Transplant. Cell. Ther."},{"key":"10.1016\/j.omton.2025.200985_bib39","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1182\/bloodadvances.2020002328","article-title":"Clinical efficacy of anakinra to mitigate CAR T-cell therapy-associated toxicity in large B-cell lymphoma","volume":"4","author":"Strati","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.omton.2025.200985_bib40","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41591-018-0041-7","article-title":"CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade letter","volume":"24","author":"Giavridis","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.omton.2025.200985_bib41","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1182\/bloodadvances.2022006983","article-title":"Anakinra utilization in refractory pediatric CAR T-cell associated toxicities","volume":"6","author":"Diorio","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.omton.2025.200985_bib42","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/s41591-023-02404-6","article-title":"CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results","volume":"29","author":"Park","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.omton.2025.200985_bib43","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1182\/blood.2021012811","article-title":"Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myeloma","volume":"139","author":"Sakemura","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.200985_bib44","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive Integration of Single-Cell Data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.omton.2025.200985_bib45","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omton.2025.200985_bib46","doi-asserted-by":"crossref","first-page":"861","DOI":"10.21105\/joss.00861","article-title":"UMAP: Uniform Manifold Approximation and Projection","volume":"3","author":"McInnes","year":"2018","journal-title":"J. Open Source Softw."},{"key":"10.1016\/j.omton.2025.200985_bib47","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"},{"key":"10.1016\/j.omton.2025.200985_bib48","article-title":"Using crispr\/cas9 to knock out gm-csf in car-t cells","volume":"2019","author":"Sterner","year":"2019","journal-title":"J. Vis. Exp."}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329925000542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329925000542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:03:32Z","timestamp":1762657412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329925000542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2950329925000542"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2025.200985","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intrinsic immunosuppressive features of monocytes suppress CAR-T19 through IL-1 pathway modulation in mantle cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2025.200985","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"200985"}}